Back to All

How Chronic Inflammation is a Cause of Systemic Disease

Webinar Date: Wednesday, August 19, 2015

Presented by Ronald McGlennen, MD

View Recording

Webinars from 2015 and on are available for CE credit - a member only benefit! Interested in becoming a member? CLICK HERE to learn more.


Inflammation is a natural response to offenses of the body, protecting us from infection, trauma, and other forces of the environment. Too much inflammation, especially occurring over the years and decades is now known to contribute to the causes of atherosclerotic vascular disease, adult-onset (Type 2) diabetes, forms of dementia and even cancer. Join us as we explore how chronic inflammation, and the risk of inflammation associated disease, is best assayed by the use of genetic testing. This lecture will outline the molecular physiology of these gene markers and discuss the translation of that genetic information to detail how inflammation causes atherosclerosis, insulin resistance/diabetes and a model of dementia.


This short lecture seeks to teach

  1. The description of the molecular genetics of gene expression and the model of how this applies to chronic inflammation
  2. Details of the mechanisms by which chronic inflammatory cells and extracellular proteins affect end organs to illustrate atherosclerosis, type 2 diabetes and dementia
  3. Outline ways in which such genetic information can be used to care for patients and construct management plans.

Speaker Bio:
Ronald McGlennen

Dr. McGlennen is President and Medical Director of Access Genetics and OralDNA Labs. He has published more than 70 scientific articles and book chapters and has served as the editor of five journals. He holds 9 issued and pending patents. He is board certified in Anatomic and Clinical Pathology and also by the American Board of Medical Genetics, with a Specialty in Clinical Molecular Genetics. He is internationally recognized as an expert in Molecular Biology and Genetics. His focus in research has been on reducing the complexity of gene based testing, including DNA chip technology and simple analytic instrumentation to better serve the community laboratory. He has served on a series of governmental and regulatory committees focused on the growth of the field of molecular diagnostics.